486 related articles for article (PubMed ID: 33089648)
21. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
[TBL] [Abstract][Full Text] [Related]
22. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.
Bossini N; Alberici F; Delbarba E; Valerio F; Manenti C; Possenti S; Econimo L; Maffei C; Pola A; Terlizzi V; Salviani C; Moscato M; Pasquali S; Zambetti N; Tonoli M; Affatato S; Pecchini P; Viola FB; Malberti F; Depetri G; Gaggiotti M; Scolari F;
Am J Transplant; 2020 Nov; 20(11):3019-3029. PubMed ID: 32627319
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Rodriguez-Gonzalez CG; Chamorro-de-Vega E; Valerio M; Amor-Garcia MA; Tejerina F; Sancho-Gonzalez M; Narrillos-Moraza A; Gimenez-Manzorro A; Manrique-Rodriguez S; Machado M; Olmedo M; Escudero-Vilaplana V; Villanueva-Bueno C; Torroba-Sanz B; Melgarejo-Ortuño A; Vicente-Valor J; Herranz A; Bouza E; Muñoz P; Sanjurjo M
Int J Antimicrob Agents; 2021 Feb; 57(2):106249. PubMed ID: 33259918
[TBL] [Abstract][Full Text] [Related]
24. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.
Vernaz N; Agoritsas T; Calmy A; Gayet-Ageron A; Gold G; Perrier A; Picard F; Prendki V; Reny JL; Samer C; Stirnemann J; Vetter P; Zanella MC; Zekry D; Baggio S
Swiss Med Wkly; 2020 Dec; 150():w20446. PubMed ID: 33382449
[TBL] [Abstract][Full Text] [Related]
25. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
Giacomelli A; Pagani G; Ridolfo AL; Oreni L; Conti F; Pezzati L; Bradanini L; Casalini G; Bassoli C; Morena V; Passerini S; Rizzardini G; Cogliati C; Ceriani E; Colombo R; Rusconi S; Gervasoni C; Cattaneo D; Antinori S; Galli M
J Med Virol; 2021 Mar; 93(3):1421-1427. PubMed ID: 32776534
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Mortality in Stable Kidney Transplant Patients Infected by SARS-CoV-2 in the South of Spain.
López V; Vázquez-Sánchez T; Casas C; Schuldt R; Alonso-Titos J; Ruiz-Esteban P; Cabello M; Hernández D
Transplant Proc; 2021 Nov; 53(9):2685-2687. PubMed ID: 34629188
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 infection in two patients following recent lung transplantation.
Koczulla RA; Sczepanski B; Koteczki A; Kuhnert S; Hecker M; Askevold I; Schneider C; Michel S; Kneidinger N
Am J Transplant; 2020 Oct; 20(10):2928-2932. PubMed ID: 32400084
[TBL] [Abstract][Full Text] [Related]
28. Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
Kim JW; Kim EJ; Kwon HH; Jung CY; Kim KC; Choe JY; Hong HL
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S253-S263. PubMed ID: 32536150
[TBL] [Abstract][Full Text] [Related]
29. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
Young BE; Ong SWX; Kalimuddin S; Low JG; Tan SY; Loh J; Ng OT; Marimuthu K; Ang LW; Mak TM; Lau SK; Anderson DE; Chan KS; Tan TY; Ng TY; Cui L; Said Z; Kurupatham L; Chen MI; Chan M; Vasoo S; Wang LF; Tan BH; Lin RTP; Lee VJM; Leo YS; Lye DC;
JAMA; 2020 Apr; 323(15):1488-1494. PubMed ID: 32125362
[TBL] [Abstract][Full Text] [Related]
30. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.
Deng L; Li C; Zeng Q; Liu X; Li X; Zhang H; Hong Z; Xia J
J Infect; 2020 Jul; 81(1):e1-e5. PubMed ID: 32171872
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
[TBL] [Abstract][Full Text] [Related]
32. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19.
Wu L; Zheng Y; Liu J; Luo R; Wu D; Xu P; Wu D; Li X
Aging (Albany NY); 2021 Apr; 13(8):10833-10852. PubMed ID: 33879634
[TBL] [Abstract][Full Text] [Related]
35. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options.
Holzhauser L; Lourenco L; Sarswat N; Kim G; Chung B; Nguyen AB
Am J Transplant; 2020 Oct; 20(10):2916-2922. PubMed ID: 32378314
[TBL] [Abstract][Full Text] [Related]
36. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH
J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).
Sánchez-Álvarez JE; Pérez Fontán M; Jiménez Martín C; Blasco Pelícano M; Cabezas Reina CJ; Sevillano Prieto ÁM; Melilli E; Crespo Barrios M; Macía Heras M; Del Pino Y Pino MD
Nefrologia (Engl Ed); 2020; 40(3):272-278. PubMed ID: 32389518
[TBL] [Abstract][Full Text] [Related]
39. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Meriglier E; Rivoisy C; Hessamfar M; Bernard N; Aureau I; Lapoirie J; Contis A; Sacher F; Sacristan B; Lahouati M; Pedeboscq S; Vandenhende MA; Bouchet S; Bonnet F
J Antimicrob Chemother; 2021 Jan; 76(2):482-486. PubMed ID: 33221868
[TBL] [Abstract][Full Text] [Related]
40. Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.
Ning L; Liu L; Li W; Liu H; Wang J; Yao Z; Zhang S; Zhao D; Nashan B; Shen A; Liu L; Li L
Am J Transplant; 2020 Jul; 20(7):1864-1868. PubMed ID: 32277555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
